Tvardi Therapeutics, Inc. (TVRD) stock
TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.01−0.09 (-8.18%)
Close on Nov 17, 2026Market cap $13.47MP/E –Yield 0.00%
Tvardi Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Tvardi Therapeutics's price to sales ratio was 5.2× on Jul 31, 2025, against 3.4× a year earlier. Over the last 5 years it ranged from 2.5× to 95.7×, with a median of 14.8×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Jul 31, 2025 | 5.2× | −4.4 |
| 2024 | Dec 31, 2024 | 9.7× | +3.9 |
| 2023 | Dec 29, 2023 | 5.7× | −38.2 |
| 2022 | Dec 30, 2022 | 43.9× | +30.3 |
| 2021 | Dec 31, 2021 | 13.7× | −63.7 |
| 2020 | Dec 31, 2020 | 77.4× | −30.5 |
| 2019 | Dec 31, 2019 | 107.9× | −118.6 |
| 2016 | Oct 31, 2016 | 226.5× | −65.5 |
| 2015 | Dec 31, 2015 | 292.0× | +81.5 |
| 2014 | Dec 31, 2014 | 210.5× | – |
See a number that looks wrong?